Corporate ActionApr 30, 2026, 11:11 AM
PVCT Stockholders to Vote on 1-for-10 to 1-for-50 Reverse Stock Split
AI Summary
Provectus Biopharmaceuticals, Inc. will hold its 2026 Annual Meeting of Stockholders on June 18, 2026, in Knoxville, Tennessee. Stockholders will vote on several key proposals, including the election of four directors, an advisory vote on executive compensation, and the ratification of CBIZ CPAs P.C. as the independent auditor. The most significant proposals involve authorizing the Board to effect a reverse stock split of common and preferred stock at a ratio between 1-for-10 and 1-for-50, and to proportionally decrease the number of authorized shares if the split is approved. The Board unanimously recommends voting "FOR" all proposals.
Key Highlights
- Annual Meeting on June 18, 2026, to vote on five proposals.
- Proposal to authorize a reverse stock split of 1-for-10 to 1-for-50 for common and preferred stock.
- Proposal to decrease authorized shares proportionally if reverse stock split is approved.
- Board unanimously recommends voting "FOR" all proposals.
- 420,279,879 shares of common stock outstanding as of April 20, 2026.
- 14,389,027 shares of Series D-1 Convertible Preferred Stock outstanding, convertible into 143,890,270 common shares.